ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 56 filers reported holding ENTELLUS MED INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,055,000 | -6.7% | 57,150 | -16.3% | 1.10% | -11.9% |
| Q2 2017 | $1,131,000 | +36.6% | 68,316 | +13.8% | 1.25% | +46.8% |
| Q1 2017 | $828,000 | -22.5% | 60,017 | +6.5% | 0.85% | -27.1% |
| Q4 2016 | $1,069,000 | -2.6% | 56,350 | +14.0% | 1.17% | +6.8% |
| Q3 2016 | $1,097,000 | +166.9% | 49,450 | +119.8% | 1.10% | +132.9% |
| Q2 2016 | $411,000 | – | 22,500 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $72,109,000 | 38.09% |
| Essex Woodlands Management, Inc. | 3,231,656 | $77,560,000 | 14.02% |
| Sand Grove Capital Management LLP | 1,364,163 | $33,627,000 | 7.25% |
| Archon Capital Management LLC | 572,804 | $13,971,000 | 7.00% |
| First Light Asset Management, LLC | 670,904 | $16,363,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $8,325,000 | 2.94% |
| Aisling Capital LLC | 528,655 | $12,894,000 | 2.55% |
| Cypress Capital Management LLC (WY) | 59,490 | $1,451,000 | 1.64% |
| Endurant Capital Management LP | 189,268 | $4,616,000 | 1.41% |
| HAVENS ADVISORS LLC | 69,028 | $1,684,000 | 1.27% |